 TORRANCE, Calif.--BUSINESS WIRE--Forte Biosciences, Inc. NASDAQ: FBRX, a clinical-stage biopharmaceutical company, today announced the issuance of an equity inducement award as required by the Nasdaq Stock Market Rules. In accordance with NASDAQ Listing Rule 5635c4, the Compensation Committee of Fortes Board of Directors approved the grant of an equity award to purchase 15,000 shares of common stock to a new non-executive employee as a material inducement to such i 